249 related articles for article (PubMed ID: 32404958)
1. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.
Zheng XZ; Qin XY; Chen SW; Wang P; Zhan Y; Zhong PP; Buza N; Jin YL; Wu BQ; Hui P
Mod Pathol; 2020 Oct; 33(10):1979-1988. PubMed ID: 32404958
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping.
Banet N; DeScipio C; Murphy KM; Beierl K; Adams E; Vang R; Ronnett BM
Mod Pathol; 2014 Feb; 27(2):238-54. PubMed ID: 23887308
[TBL] [Abstract][Full Text] [Related]
3. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
4. Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.
Xing D; Adams E; Huang J; Ronnett BM
Mod Pathol; 2021 May; 34(5):961-982. PubMed ID: 33024305
[TBL] [Abstract][Full Text] [Related]
5. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization.
Lai CY; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Tsao SW; Cheung AN
Mod Pathol; 2004 Jan; 17(1):40-8. PubMed ID: 14631372
[TBL] [Abstract][Full Text] [Related]
6. Precise DNA genotyping diagnosis of hydatidiform mole.
Lipata F; Parkash V; Talmor M; Bell S; Chen S; Maric V; Hui P
Obstet Gynecol; 2010 Apr; 115(4):784-794. PubMed ID: 20308840
[TBL] [Abstract][Full Text] [Related]
7. [Clinical application of STR genotyping diagnosis for hydatidiform mole and nonmolar gestation].
Zheng XZ; Qin XY; Wang P; Xu F; Ma JH; Wang XL; Chen SW; Feng WQ; Zhu L; Yin CH; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):609-615. PubMed ID: 30107666
[No Abstract] [Full Text] [Related]
8. Invasive Complete Hydatidiform Moles: Analysis of a Case Series With Genotyping.
Bynum J; Murphy KM; DeScipio C; Beierl K; Adams E; Anderson D; Vang R; Ronnett BM
Int J Gynecol Pathol; 2016 Mar; 35(2):134-41. PubMed ID: 26535984
[TBL] [Abstract][Full Text] [Related]
9. Twin/Multiple Gestations With a Hydatidiform Mole: Clinicopathologic Analysis of 21 Cases With Emphasis on Molecular Genotyping and Parental Contribution.
Xing D; Adams E; Zou YS; Morsberger L; Scanga LR; Gao FF; Barker N; Vang R; Ronnett BM
Am J Surg Pathol; 2022 Sep; 46(9):1180-1195. PubMed ID: 35796652
[TBL] [Abstract][Full Text] [Related]
10. Malignant potential of homozygous and heterozygous complete moles.
Wake N; Seki T; Fujita H; Okubo H; Sakai K; Okuyama K; Hayashi H; Shiina Y; Sato H; Kuroda M
Cancer Res; 1984 Mar; 44(3):1226-30. PubMed ID: 6318983
[TBL] [Abstract][Full Text] [Related]
11. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
12. The propensity to malignancy of dispermic heterozygous moles.
Wake N; Fujino T; Hoshi S; Shinkai N; Sakai K; Kato H; Hashimoto M; Yasuda T; Yamada H; Ichinoe K
Placenta; 1987; 8(3):319-26. PubMed ID: 2821529
[TBL] [Abstract][Full Text] [Related]
13. Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.
Xing D; Miller K; Beierl K; Ronnett BM
Am J Surg Pathol; 2022 Jan; 46(1):18-32. PubMed ID: 34074808
[TBL] [Abstract][Full Text] [Related]
14. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
15. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease.
Kaneki E; Kobayashi H; Hirakawa T; Matsuda T; Kato H; Wake N
Cancer Sci; 2010 Jul; 101(7):1717-21. PubMed ID: 20518791
[TBL] [Abstract][Full Text] [Related]
16. Genetics of gestational trophoblastic disease.
Fisher RA; Maher GJ
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():29-41. PubMed ID: 33685819
[TBL] [Abstract][Full Text] [Related]
17. Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in China.
Jiao L; Wang Y; Jiang J; Wang X; Zhang W; Zhu C; Xiang Y
Int J Gynecol Cancer; 2022 Feb; 32(2):147-152. PubMed ID: 34799419
[TBL] [Abstract][Full Text] [Related]
18. Hydatidiform Moles: Ancillary Techniques to Refine Diagnosis.
Ronnett BM
Arch Pathol Lab Med; 2018 Dec; 142(12):1485-1502. PubMed ID: 30500280
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes.
Khawajkie Y; Mechtouf N; Nguyen NMP; Rahimi K; Breguet M; Arseneau J; Ronnett BM; Hoffner L; Lazure F; Arnaud M; Peers F; Tan L; Rafea BA; Aguinaga M; Horowitz NS; Ao A; Tan SL; Brown R; Buckett W; Surti U; Hovanes K; Sahoo T; Sauthier P; Slim R
Mod Pathol; 2020 May; 33(5):880-892. PubMed ID: 31857680
[TBL] [Abstract][Full Text] [Related]
20. Recurrent Androgenetic Complete Hydatidiform Moles with p57
Li MW; Li F; Cheng J; Wang F; Zhou P
Reprod Sci; 2022 Jun; 29(6):1749-1755. PubMed ID: 34606065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
